 Chemotherapy high dose ifosfamide/mesna cisplatin treatment ovarian cancer study Grupo Estudio Tratamiento Latino-Americano del Cancer Twenty-one evaluable patients FIGO II-IV epithelial ovarian cancer median age range years ifosfamide IF ml saline solution hour intravenous i.v infusion days IF dose i.v injection hours IF dose oral route hours days ml saline solution hour i.v infusion days Cycles weeks patients metastatic lesions mesentery pleura colon cervix abdominal wall lung liver bladder nodes Toxicity mild patients alopecia nausea Neutropenia mild patient mild brain confusion patients microscopic hematuria complete responses partial responses overall objective response second look performance patients complete response patients pathological complete response pathological partial response median duration complete response months median partial response duration months numbers small data combination chemotherapy high dose ifosfamide/mesna cisplatin active treatment advanced ovarian carcinoma